Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

Hua Han Health Industry / Equity Bottom-Up

<ul>
 <li>
<a href="https://smartkarma.com/entities/hua-han-health-industry-holdings-limited">Hua Han Health Industry</a> Holdings Limited is a delisted and defunct company, having had its listing on the Hong Kong Stock Exchange cancelled on December 16, 2020.</li>
 <li>The company's collapse was triggered by allegations of fraudulent sales and profits from short-seller Emerson Analytics in August 2016, leading to a trading suspension on September 27, 2016, from which the stock never recovered.</li>
 <li>Subsequent investigations uncovered a significant money laundering scheme involving the misappropriation of company funds, leading to the conviction and imprisonment of the former financial controller in October 2025.</li>
</ul>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


  
Hua Han Health Industry Holdings Limited is a delisted and defunct company, having had its listing on the Hong Kong Stock Exchange cancelled on December 16, 2020.
  The company's collapse was triggered by allegations of fraudulent sales and profits from short-seller Emerson Analytics in August 2016, leading to a trading suspension on September 27, 2016, from which the stock never recovered.
  Subsequent investigations uncovered a significant money laundering scheme involving the misappropriation of company funds, leading to the conviction and imprisonment of the former financial controller in October 2025.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: Hua Han Health Industry (587 HK) - Aug 2026

HK/China Equity Long-Short

Osbert Tang, CFA

<ul>
<li>
<a href="https://www.smartkarma.com/entities/china-conch-venture-holdings-ltd" target="_blank" data-smartkarma-citation="entities:19943:1" rel="noopener">China Conch Venture Holdings (586 HK)</a> is now at negative stub value, the low-end since 2020. This is despite a 16.4% growth in 1H22 core earnings to Rmb542m.</li>
<li>The company's waste-to-energy (WTE) capacity will increase by 25% in FY23 and its internal target calls for an earnings CAGR of 33% between FY21 and FY25 for WTE segment.</li>
<li>We should not underestimate the potential from new business initiatives including cathode and anode materials and lithium battery recycling. They have good medium-to-long term exposure to China's new energy industry.</li>
</ul>



China Conch Venture Holdings (586 HK) is now at negative stub value, the low-end since 2020. This is despite a 16.4% growth in 1H22 core earnings to Rmb542m.
The company's waste-to-energy (WTE) capacity will increase by 25% in FY23 and its internal target calls for an earnings CAGR of 33% between FY21 and FY25 for WTE segment.
We should not underestimate the potential from new business initiatives including cathode and anode materials and lithium battery recycling. They have good medium-to-long term exposure to China's new energy industry.


Conch Venture (586 HK): An Overlooked Value Play

Thematic (Sector/Industry)

<ul>
<li>Our positive calls on <a href="https://www.smartkarma.com/entities/fu-shou-yuan-international" target="_blank" data-smartkarma-citation="entities:18168:1" rel="noopener">Fu Shou Yuan (1448 HK)</a> and <a href="https://www.smartkarma.com/entities/air-china-ltd-h" target="_blank" data-smartkarma-citation="entities:8239:1" rel="noopener">Air China Ltd (753 HK)</a> and negative call on <a href="https://www.smartkarma.com/entities/china-conch-environment-protection-holdings-ltd" target="_blank" data-smartkarma-citation="entities:4827:1" rel="noopener">Conch Environment (587 HK)</a> have generated the best wins in 2022.</li>
<li>These calls achieved returns of 56.8%, 34.2% and 43.5%, respectively, which we think are remarkable given the losses of 16.3% for HSI and 19.3% for HSCEI YTD.</li>
<li>In 2023, we expect Fu Shou Yuan <a href="https://www.smartkarma.com/entities/fu-shou-yuan-international" target="_blank" data-smartkarma-citation="entities:18168:1" rel="noopener"></a>continue to do well and Conch Environment to remain under pressure. It may be prudent to take some profit on Air China. <a href="https://www.smartkarma.com/entities/air-china-ltd-h" target="_blank" data-smartkarma-citation="entities:8239:1" rel="noopener"></a> </li>
</ul>


Our positive calls on Fu Shou Yuan (1448 HK) and Air China Ltd (753 HK) and negative call on Conch Environment (587 HK) have generated the best wins in 2022.
These calls achieved returns of 56.8%, 34.2% and 43.5%, respectively, which we think are remarkable given the losses of 16.3% for HSI and 19.3% for HSCEI YTD.
In 2023, we expect Fu Shou Yuan continue to do well and Conch Environment to remain under pressure. It may be prudent to take some profit on Air China.  


Our Three Best Calls in 2022: Review and Outlook for 2023

Transport Sector, China and Asia-focused Research

Charles De Trenck

This is an invest-able idea at the private level  with long term benefits. Both for the body, and for other ideas as well.Ever since I turned over a new leaf vis a vis health five plus years ago, I have explored active alternative health solutions. I have a long list of things I have solved and people I have seen gain real improvements from alternative treatments.  I have seen real growth in options to treatment of severe conditions.Most interesting perhaps has been learning about the benefits…

This is an invest-able idea at the private level  with long term benefits. Both for the body, and for other ideas as well.Ever since I turned over a new leaf vis a vis health five plus years ago, I have explored active alternative health solutions. I have a long list of things I have solved and people I have seen gain real improvements from alternative treatments.  I have seen real growth in options to treatment of severe conditions.Most interesting perhaps has been learning about the benefits…

Energy Medicine. Personal Experience. Impact. Growth in Asia. Ideas

<ul>
<li>
<a href="https://www.smartkarma.com/entities/china-conch-venture-holdings-ltd" target="_blank" data-smartkarma-citation="entities:19943:1" rel="noopener">China Conch Venture Holdings (586 HK)</a>'s parent will increase its stake through open market purchase. We estimate the added 10.6% stake will involve HK$2.6bn.</li>
<li>Its earnings will return to a growth track in the next three years, with a CAGR of 15.8%, and the parent's move shows strong confidence in the company.</li>
<li>At 7.2x and 6.6x PERs for FY26F and FY27F, the multiples are only slightly above average, and this is a cheaper way to buy <a href="https://www.smartkarma.com/entities/anhui-conch-cement-co-ltd" target="_blank" data-smartkarma-citation="entities:159:1" rel="noopener">Anhui Conch Cement (914 HK)</a>. </li>
</ul>



China Conch Venture Holdings (586 HK)'s parent will increase its stake through open market purchase. We estimate the added 10.6% stake will involve HK$2.6bn.
Its earnings will return to a growth track in the next three years, with a CAGR of 15.8%, and the parent's move shows strong confidence in the company.
At 7.2x and 6.6x PERs for FY26F and FY27F, the multiples are only slightly above average, and this is a cheaper way to buy Anhui Conch Cement (914 HK). 


Conch Venture (586 HK): Increasing Stake by the Parent

Hong Kong

Hua Han Health Industry is an investment holding company primarily engaged in the manufacturing and sale of pharmaceutical and biopharmaceutical products. The company also specializes in medical operations, hospital management, and the research, manufacture, and sale of traditional Chinese medicines in the People's Republic of China. Headquartered in Hong Kong, the company was established in 2002.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Hua Han Health Industry (587 HK)

Primer: Hua Han Health Industry (587 HK) - Aug 2026

Hua Han Health Industry Holdings Limited is a delisted and defunct company, having had its listing on the Hong Kong Stock Exchange cancelled on...

αSK Primers

Conch Venture (586 HK): An Overlooked Value Play

The market has deeply undervalued Conch Venture's waste-to-energy business as reflected by the negative stub value. New business initiatives and...

Osbert Tang, CFA

Our Three Best Calls in 2022: Review and Outlook for 2023

In 2023, we expect share prices of Fu Shou Yuan to continue to do well and Conch Environment to remain under pressure. For Air China, given rich...

Osbert Tang, CFA

Energy Medicine. Personal Experience. Impact. Growth in Asia. Ideas

This is an invest-able idea at the private level with long term benefits. Both for the body, and for other ideas as well.Ever since I turned over...

Charles De Trenck

Conch Venture (586 HK): Increasing Stake by the Parent

Conch Venture reported an 11.1% increase in FY25 earnings, below expectations. However, in 2H25, the main operations (excluding Anhui Conch Cement)...

Osbert Tang, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)